Used as a key intermediate in the synthesis of fluorinated pharmaceutical compounds, particularly in the development of selective kinase inhibitors. Its structure supports the creation of bioactive molecules with enhanced metabolic stability and binding affinity. Commonly employed in medicinal chemistry for constructing fluorinated aromatic scaffolds in drug candidates targeting oncology and inflammatory diseases. Also utilized in the preparation of radiolabeled analogs for positron emission tomography (PET) imaging due to the presence of fluorine, enabling non-invasive diagnostic applications.